The purpose of this study was to investigate the possible association between sclerostin concentrations with leptin, between sclerostin and selected poor prognostic factors of CKD progression such as hyperglycemia, insulin resistance, anemia, and high inflammatory status, and between sclerostin and nutritional parameters in non-dialysis CKD male patients. Here, SOST is linked to anemia.